JACOBUS 25 102 (Dapsone 25 mg)

Pill imprint JACOBUS 25 102 has been identified as Dapsone 25 mg.

Dapsone is used in the treatment of dermatitis herpetiformis; bullous pemphigoid; leprosy; toxoplasmosis, prophylaxis; leukocytoclastic vasculitis (and more), and belongs to the drug class leprostatics. Risk cannot be ruled out during pregnancy. Dapsone 25 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for JACOBUS 25 102 (Dapsone 25 mg)

Dapsone 25 mg JACOBUS 25 102 Front
Dapsone 25 mg JACOBUS 25 102 Back
Dapsone 25 mg JACOBUS 25 102
Dapsone
Imprint:
JACOBUS
25 102
Strength:
25 mg
Color:
White
Size:
6.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Leprostatics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Jacobus Pharmaceutical Company
National Drug Code (NDC):
49938-0102
Inactive Ingredients:
silicon dioxide
magnesium stearate
microcrystalline cellulose
corn starch
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-2817 Physicians Total Care Inc (repackager)
55289-0188 PDRX Pharmaceuticals Inc (repackager)
68258-9091 Dispensing Solutions Inc. (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)